Pharmacokinetics of New Antiherpetic Agents
- 1 November 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (5) , 333-340
- https://doi.org/10.2165/00003088-199529050-00003
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humansAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairmentClinical Pharmacology & Therapeutics, 1994
- Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteersEuropean Journal of Clinical Pharmacology, 1994
- Metabolic and pharmacokinetic studies following oral administration of14C-famciclovir to healthy subjectsXenobiotica, 1994
- Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteersClinical Pharmacology & Therapeutics, 1993
- Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusAntimicrobial Agents and Chemotherapy, 1992
- Acyclovir: A Decade LaterNew England Journal of Medicine, 1992
- AcyclovirDrugs, 1989
- Human gastrointestinal absorption of acyclovir from tablet duodenal infusion and sipped solution.British Journal of Clinical Pharmacology, 1986
- Pharmacokinetics of acyclovir after intravenous and oral administrationJournal of Antimicrobial Chemotherapy, 1983